Back

Kodiak Sciences to report DAYBREAK Phase 3 results Sept. 28

Verifying
  • Kodiak Sciences will report DAYBREAK Phase 3 results for Zenkuda and KSI-501.
  • 8:30 a.m. Eastern Time on September 28, 2026, is the webcast start.
  • Kodiak has three late-stage clinical programs, including KSI-101 Phase 3 studies.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Kodiak Sciences to report DAYBREAK Phase 3 results Sept. 28 - CoinPost Terminal